PIK3CA and breast cancer: In breast cancer, mutations in the kinase domain are of better prognostic value than mutations in the helical domain, which might be explained by this synergy of RAS with oncogenic helical domain of PIK3CA. We therefore compared specific mutations in RAS isoforms and PIK3CA domains in relation to prognostic factors.